Transcript Diapositiva 1

ESMO, 9-10 October 2010
Status of cancer in Europe
Now
Dr. Andrea Micheli
Director
Descriptive Studies and Health Planning Unit
Fondazione IRCCS “Istituto Nazionale dei Tumori”
Milan
EUROPE in the WORLD
GROSS DOMESTIC PRODUCT (GDP) AND CANCER INCIDENCE
Age-standardized incidence rates, World Standard Population per 100,000, GDP: at current prices US $, 2006.
Source: GLOBOCAN 2002, IARC & United Nations (UN)
EUROPE in the WORLD
GROSS DOMESTIC PRODUCT (GDP) AND CANCER MORTALITY
Age-Standardized incidence rates, World Standard Population per 100,000, GDP: at current prices US $, 2006.
Source: GLOBOCAN 2002, IARC & United Nations (UN)
GDP AND EPIDEMIOLOGICAL CANCER DATA
All cancers M & F
COUNTRIES BY QUARTILE of
GDP per capita ($PPP)
Incidence
Mortality
per 100,000
per 100,000
5 yrs
Survival
%
GDP < 20,000
336
209
-
363
172
50
411
171
49
405
176
53
(BUL, ROM, LAT, PL, LIT, HUN, EST, SK)
20,000 < GDP < = 30,000
(PT, MT, CZK, SLO, CY, HEL, S, I)
30,000 < GDP < = 36,000
(F, D, FIN, UK, B, SW, DK)
GDP > 36,000
(A, ICE, NL, CH, IRE, N, LUX)
Sources: Ferlay et al. EJC, 2010. EUROCARE-4. For GDP International Monetary Fund
GDP and age-standardized incidence rates for all cancers. Men
Sources: Human Development Report 2009; Ferlay et al. 2008
GDP and age-standardized mortality rates for all cancers. Men
Disks are proportional to the public health expenditure ($ PPP)
Sources: Human Development Report 2009; Ferlay et al. 2008
EUROCARE-4
5-year relative survival, all cancers
countries are ordered by Total Expenditure on Health
Europe
Berrino F. et al, The Lancet Oncology, 2007
5 YEARS RELATIVE SURVIVAL FOR ALL CANCERS
Ranked by 1995 TNEH
Source: Verdecchia A. et al. European Journal of Public Health, 2008
5 YRS AGE-ADJUSTED BREAST CANCER
RELATIVE SURVIVAL
Standard: ICSS
5 YRS AGE-ADJUSTED COLORECTAL CANCER
RELATIVE SURVIVAL, MEN
Standard: ICSS
5 YRS AGE-ADJUSTED COLORECTAL CANCER
RELATIVE SURVIVAL, WOMEN
Standard: ICSS
5-YRS ALL CANCERS RELATIVE SURVIVAL TREND IN EUROPE
Source: Verdecchia A. et al. EJC 2009
LIFE
EXPECTANCY
TRENDS IN
EUROPE
Inequalities
in health have
increased
Source: United Nations
Population Division
Cancer in Europe: trends & inequalities
• Incidence: number of new cases is expected to continue to
increase in the next years
INVESTMENT IN PRIMARY PREVENTION IS THE KEY
• Survival: expected to improve as in last decade but with lower
performance in Low Income Countries
COSTS REDUCTION YET KEEPING THE SAME OUTCOME IS
THE KEY
• Prevalence: expected to explode in next years
LONGTERM SURVIVORS NEEDS MUST BE CONSIDERED
• Mortality: expected to reinforce the tendency in its reduction but
with lower rate in some countries
DEVELOPMENT OF CANCER PLANS IS THE KEY TO AVOID
AVOIDABLE DEATHS
Source: Pierotti M. et al. Tumori 2009
The burden of Cancer in Europe
• Incidence: 3.2 million cancer
53% (1.7 million) in men and 47% (1.5 million) in women
colorectal cancers (436,000 cases, 13.6% of the total)
breast cancer (421,000, 13.1%)
lung cancer (391,000, 12.2%)
prostate cancer (382,000, 11.9%)
• Mortality: 1.72 million deaths
56% (1 million) in men and 44% (0.7 million) in women
lung cancer (342,000 deaths, 19.9% of the total),
colorectal cancer (212,000 deaths, 12.3%),
breast cancer (129,000, 7.5%)
stomach cancer (117,000, 6.8%)
Source: Ferlay et al. EJC 2010
Scientific contributions in cancer domain
and cancer burden in 2002
English language
Number of cancer publications per year
Number of new cancer cases per year
United States
Japan
Germany
UK
France
China
Italy
Canada
Spain
Mexico
Korea
Brazil
India
Netherland
Australia
United States
Japan
Germany
UK
France
China
Italy
Canada
Spain
Mexico
Korea
Brazil
India
Netherland
Australia
0
1,000
2,000 3,000 4,000 5,000
6,000 7,000
0
500,000 1,000,000 1,500,000 2,000,000 2,500,000
"the 15 most wealthy countries are ordered by decreasing gross domestic product level"
Source: Pierotti M. et al. Tumori 2009